Bladder Cancer

  • James S. Butler
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Bladder cancer is one of the most common malignancies of the urinary tract and is a disease that ranges from localized disease treated with cystoscopy and transurethral tumor resection only to metastatic disease that requires systemic therapy. Although the majority of patients present with superficial disease, approximately one third of patients with bladder cancer will have muscle invasion, and localized invasive disease often requires multidisciplinary management, particularly if bladder preservation is to be attempted.

Keywords

Bladder Cancer Clin Oncol Radiat Oncol Biol Phys Bladder Tumor Radical Cystectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abol-Enein H, Kava BR, Carmack AJ (2007) Nonurothelial cancer of the bladder. Urology 69(1 Suppl):93–104PubMedCrossRefGoogle Scholar
  2. Advanced Bladder Cancer Meta-Analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361:1927–1934CrossRefGoogle Scholar
  3. Advanced Bladder Cancer (ABC) Meta-Analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 48:189–199CrossRefGoogle Scholar
  4. Anderström C, Johansson S, Nilsson S et al. (1983) A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 9:142–147PubMedGoogle Scholar
  5. Anderström C, Johansson SL, von Schultz L (1983) Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer 52:1273–1280PubMedCrossRefGoogle Scholar
  6. Bessell EM, Taylor J, Moloney AJ et al. (1993) Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years. Radiother Oncol 29:344–346PubMedCrossRefGoogle Scholar
  7. Bjerre BD, Johansen C, Steven K (1995) Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol 75:200–205PubMedCrossRefGoogle Scholar
  8. Blank LE, Koedooder K, van Os R et al. (2007) Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Int J Radiat Oncol Biol Phys 69:454–458PubMedGoogle Scholar
  9. Bono AV, Benvenuti C, Reali L et al. (1989) Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res 303:533–540PubMedGoogle Scholar
  10. Caffo O, Fellin G, Graffer U et al. (1996) Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer 78:1089–1097PubMedCrossRefGoogle Scholar
  11. Chakravarti A, Winter K, Wu CL et al. (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62:309–317PubMedGoogle Scholar
  12. Chung PW, Bristow RG, Milosevic MF et al. (2007) Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol 25:303–309PubMedGoogle Scholar
  13. Cole CJ, Pollack A, Zagars GK et al. (1995) Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys 32:331–340PubMedCrossRefGoogle Scholar
  14. Coppin CM, Gospodarowicz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14:2901–2907PubMedGoogle Scholar
  15. Daehlin L, Haukaas S, Maartmann-Moe H et al. (1999) Survival after radical treatment for transitional cell carcinoma of the bladder. Eur J Surg Oncol 25:66–70PubMedCrossRefGoogle Scholar
  16. Dandekar NP, Dalal AV, Tongaonkar HB et al. (1997) Adenocarcinoma of bladder. Eur J Surg Oncol 23:157–160PubMedCrossRefGoogle Scholar
  17. Dotan ZA, Kavanagh K, Yossepowitch O et al. (2007) Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178:2308–2312PubMedCrossRefGoogle Scholar
  18. Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7:299–310PubMedCrossRefGoogle Scholar
  19. Felix AS, Soliman AS, Khaled H et al. (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19:421–429PubMedCrossRefGoogle Scholar
  20. Fossa SD, Aass N, Ous S et al. (1996) Survival after curative treatment of muscle-invasive bladder cancer. Acta Oncol 35[Suppl 8]:59–65PubMedCrossRefGoogle Scholar
  21. Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155:495–499PubMedCrossRefGoogle Scholar
  22. Ghoneim MA, Ashamallah AK, Awaad HK et al. (1985) Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134:266–268PubMedGoogle Scholar
  23. Goodman GB, Hislop TG, Elwood JM et al. (1981) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7:569–573PubMedGoogle Scholar
  24. Goffinet DR, Schneider MJ, Glatstein EJ et al. (1975) Bladder cancer: results of radiation therapy in 384 patients. Radiology 117:149–153PubMedGoogle Scholar
  25. Gospodarowicz MK, Hawkins NV, Rawlings GA et al. (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142:1448–1453PubMedGoogle Scholar
  26. Grossman HB, Natale RB, Tangen CM et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859–866PubMedCrossRefGoogle Scholar
  27. Hagan MP, Winter KA, Kaufman DS et al. (2003) RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57:665–672PubMedGoogle Scholar
  28. Hall R (2002) On behalf of the International Collaboration of Trialists of the MRC Advanced Bladder Cancer Group: updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. Proc Am Soc Clin Oncol 21:178(abstract)Google Scholar
  29. Hardt J, Filipas D, Hohenfellner R et al. (2000) Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study. Qual Life Res 9:1–12PubMedCrossRefGoogle Scholar
  30. Haresh KP, Julka PK, Sharma DN et al. (2007) A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer. J Cancer Res Ther 3:81–85PubMedCrossRefGoogle Scholar
  31. Harker WG, Meyers FJ, Freiha FS et al. (1985) Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol 3:1463–1470PubMedGoogle Scholar
  32. Hart S, Skinner EC, Meyerowitz BE et al. (1999) Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral Kock pouch. J Urol 162:77–81PubMedCrossRefGoogle Scholar
  33. Hautmann RE, Gschwend JE, de Petriconi RC et al. (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176:486–492PubMedCrossRefGoogle Scholar
  34. Heicappell R, Muller-Mattheis V, Reinhardt M et al. (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 36:582–587PubMedCrossRefGoogle Scholar
  35. Henningsohn L, Wijkström H, Dickman PW et al. (2002) Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62:215–225PubMedCrossRefGoogle Scholar
  36. Holzbeierlein JM, Lopez-Corona E, Bochner BH (2004) Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol 172:878–881PubMedCrossRefGoogle Scholar
  37. Housset M, Maulard C, Chretien Y et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11:2150–2157PubMedGoogle Scholar
  38. Huncharek M, Muscat J, Geschwind JF et al. (1998) Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis. Anticancer Res 18:1931–1934PubMedGoogle Scholar
  39. Jenkins BJ, Caulfield MJ, Fowler CG et al. (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62:343–346PubMedCrossRefGoogle Scholar
  40. Johnson DE, Schoenwald MB, Ayala AG et al. (1976) Squamous cell carcinoma of the bladder. J Urol 115:542–544PubMedGoogle Scholar
  41. Kassouf W, Swanson D, Kamat AM et al. (2006) Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the MD Anderson Cancer Center experience. J Urol 175:2058–2062PubMedCrossRefGoogle Scholar
  42. Kaufman D, Raghavan D, Carducci M et al. (2000a) Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. J Clin Oncol 18:1921–1927PubMedGoogle Scholar
  43. Kaufman DS, Winter KA, Shipley WU et al. (2000b) The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5:471–476PubMedCrossRefGoogle Scholar
  44. Kaufman DS, Winter KA, Shipley WU et al. (2005) Muscle-invading bladder cancer, RTOG Protocol 99-06: Initial report of a phase I/II trial of selective bladder-conservation employing TURBT, accelerated irradiation sensitized with cisplatin and paclitaxel followed by adjuvant cisplatin and gemcitabine chemotherapy. J Clin Oncol 2005 ASCO Annual Meeting Proceedings 23[1 Suppl]:4506Google Scholar
  45. Kosuda S, Kison PV, Greenough R et al. (1997) Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 24:615–620PubMedGoogle Scholar
  46. Lagwinski N, Thomas A, Stephenson AJ et al. (2007) Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 31:1777–1787PubMedCrossRefGoogle Scholar
  47. Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61:109–118PubMedCrossRefGoogle Scholar
  48. Madersbacher S, Hochreiter W, Burkhard F et a. (2003) Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696PubMedCrossRefGoogle Scholar
  49. Mameghan H, Fisher R, Mameghan J et al. (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31:247–254PubMedGoogle Scholar
  50. Mallampati GK, Siegelman ES (2004) MR imaging of the bladder. Magn Reson Imaging Clin N Am 12:545–555PubMedCrossRefGoogle Scholar
  51. Malmström PU, Rintala E, Wahlqvist R et al. (1996) Five-year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 155:1903–1906PubMedCrossRefGoogle Scholar
  52. Månsson A, Johnson G, Månsson W (1988) Quality of life after cystectomy. Comparison between patients with conduit and those with continent caecal reservoir urinary diversion. Br J Urol 62:240–245PubMedCrossRefGoogle Scholar
  53. MRC/ EORTC (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354:533–540CrossRefGoogle Scholar
  54. National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: Bladder cancer. Available at http://www.nccn.org Accessed on 24 February 2008Google Scholar
  55. Nocks BN, Heney NM, Daly JJ (1983) Primary adenocarcinoma of urinary bladder. Urology 21:26–29PubMedCrossRefGoogle Scholar
  56. Parsons JT, Million RR (1989) Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s. Semin Surg Oncol 5:255–265PubMedCrossRefGoogle Scholar
  57. Pawinski A, Sylvester R, Kurth KH et al. (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol 156:1934–1940PubMedCrossRefGoogle Scholar
  58. Quilty PM, Duncan W (1986) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12:861–865PubMedGoogle Scholar
  59. Raleigh ED, Berry M, Montie JE (1995) A comparison of adjustments to urinary diversions: a pilot study. J Wound Ostomy Continence Nurs 22:58–63PubMedGoogle Scholar
  60. Richie JP, Waisman J, Skinner DG et al. (1976) Squamous carcinoma of the bladder: treatment by radical cystectomy. J Urol 115:670–672PubMedGoogle Scholar
  61. Robinson P, Collins CD, Ryder WD et al. (2000) Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapy. Clin Radiol 55:301–306PubMedCrossRefGoogle Scholar
  62. Rödel C, Grabenbauer GG, Kühn R et al. (2002) Combinedmodality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071PubMedCrossRefGoogle Scholar
  63. Rundle JS, Hart AJ, McGeorge A et al. (1982) Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol 54:522–526PubMedCrossRefGoogle Scholar
  64. Sengeløv L, Kamby C, Lund B et al. (1998) Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. J Clin Oncol 16:3392–3397PubMedGoogle Scholar
  65. Serretta V, Pomara G, Piazza F et al. (2000) Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 37:85–89PubMedCrossRefGoogle Scholar
  66. Sherif A, Rintala E, Mestad O et al. (2002) Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-Nordic cystectomy trial 2. Scand J Urol Nephrol 36:419–425PubMedCrossRefGoogle Scholar
  67. Shipley WU, Rose MA, Perrone TL et al. (1985) Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134:679–683PubMedGoogle Scholar
  68. Shipley WU, Prout GR Jr, Einstein AB et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931–935PubMedCrossRefGoogle Scholar
  69. Shipley WU, Winter KA, Kaufman DS et al. (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16:3576–3583PubMedGoogle Scholar
  70. Shipley WU, Kaufman DS, Zehr E et al. (2002) Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60:62–67PubMedCrossRefGoogle Scholar
  71. Siefker-Radtke AO, Dinney CP, Abrahams NA et al. (2004) Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the MD Anderson cancer experience. J Urol 172:481–484PubMedCrossRefGoogle Scholar
  72. Skinner DG, Daniels JR, Russell CA et al. (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459–464PubMedGoogle Scholar
  73. Smith JA Jr, Crawford ED, Paradelo JC et al. (1997) Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. J Urol 157:805–807PubMedCrossRefGoogle Scholar
  74. Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666–675PubMedGoogle Scholar
  75. Sternberg CN, Yagoda A, Scher HI et al. (1989) Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64:2448–2458PubMedCrossRefGoogle Scholar
  76. Stöckle M, Meyenburg W, Wellek S et al. (1995) Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153:47–52PubMedCrossRefGoogle Scholar
  77. Studer UE, Bacchi M, Biedermann C et al. (1994) Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152:81–84PubMedGoogle Scholar
  78. Sved P, Gomez P, Manoharan M et al. (2004) Small cell carcinoma of the bladder. BJU Int 94:12–17PubMedCrossRefGoogle Scholar
  79. Swanson DA, Liles A, Zagars GK (1990) Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 143:37–40PubMedGoogle Scholar
  80. Sylvester RJ, van der Meijden AP, Witjes JA et al. (2005) Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174:86–91PubMedCrossRefGoogle Scholar
  81. Tekes A, Kamel I, Imam K et al. (2005) Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am J Roentgenol 184:121–127Google Scholar
  82. Tester W, Porter A, Asbell S et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25:783–790PubMedGoogle Scholar
  83. Tester W, Caplan R, Heaney J et al. (1996) Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14:119–126PubMedGoogle Scholar
  84. Tonoli S, Bertoni F, De Stefani A et al. (2006) Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol (R Coll Radiol) 18:52–59Google Scholar
  85. Von der Maase H, Hansen SW, Roberts JT et al. (2001) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 19:1229–1231Google Scholar
  86. Wasco MJ, Daignault S, Zhang Y et al. (2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70:69–74PubMedCrossRefGoogle Scholar
  87. Zaghloul MS, Nouh A, Nazmy M et al. (2006) Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 24:13–20PubMedGoogle Scholar
  88. Zietman AL, Sacco D, Skowronski U et al. (2003) Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170:1772–1776PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • James S. Butler
    • 1
  1. 1.Department of Radiation OncologyMaimonides Cancer CenterBrooklynUSA

Personalised recommendations